ZA938915B - Treatment of viral infections by conjunctive therapy with acyclovir-like compounds and a 2'-vynyl substituted nucleoside analog - Google Patents

Treatment of viral infections by conjunctive therapy with acyclovir-like compounds and a 2'-vynyl substituted nucleoside analog

Info

Publication number
ZA938915B
ZA938915B ZA938915A ZA938915A ZA938915B ZA 938915 B ZA938915 B ZA 938915B ZA 938915 A ZA938915 A ZA 938915A ZA 938915 A ZA938915 A ZA 938915A ZA 938915 B ZA938915 B ZA 938915B
Authority
ZA
South Africa
Prior art keywords
acyclovir
vynyl
compounds
nucleoside analog
treatment
Prior art date
Application number
ZA938915A
Other languages
English (en)
Inventor
Sai P Sunkara
James R Mccarthy
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA938915B publication Critical patent/ZA938915B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA938915A 1992-12-03 1993-11-29 Treatment of viral infections by conjunctive therapy with acyclovir-like compounds and a 2'-vynyl substituted nucleoside analog ZA938915B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98475792A 1992-12-03 1992-12-03

Publications (1)

Publication Number Publication Date
ZA938915B true ZA938915B (en) 1994-08-02

Family

ID=25530838

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA938915A ZA938915B (en) 1992-12-03 1993-11-29 Treatment of viral infections by conjunctive therapy with acyclovir-like compounds and a 2'-vynyl substituted nucleoside analog

Country Status (17)

Country Link
EP (1) EP0671918B1 (xx)
JP (1) JPH08503942A (xx)
KR (1) KR100297568B1 (xx)
AT (1) ATE153533T1 (xx)
AU (1) AU678789B2 (xx)
CA (1) CA2150671C (xx)
DE (1) DE69311135T2 (xx)
DK (1) DK0671918T3 (xx)
ES (1) ES2105599T3 (xx)
GR (1) GR3024289T3 (xx)
HU (1) HUT72604A (xx)
IL (1) IL107818A (xx)
MX (1) MX9307639A (xx)
NO (1) NO952212D0 (xx)
NZ (1) NZ258015A (xx)
WO (1) WO1994012188A1 (xx)
ZA (1) ZA938915B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996001638A1 (en) * 1994-07-11 1996-01-25 Hoechst Marion Roussel, Inc. Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
DE10343365A1 (de) * 2003-09-17 2005-04-14 Biosphings Ag Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1585A1 (fr) * 1982-02-12 1985-02-22 Ens Bio Logicals Inc Procede de fabrication de compositions antivirales
IT1170232B (it) * 1983-10-31 1987-06-03 Anna Gioia Stendardi Composizioni terapeutiche ad attivita' antivirale
JPH0232093A (ja) * 1988-06-08 1990-02-01 Merrell Dow Pharmaceut Inc 抗レトロウィルスジフルオロ化ヌクレオシド類
ZA898567B (en) * 1988-11-15 1990-08-29 Merrell Dow Pharma Novel 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine,uridine and guanosine derivatives
EP0468119A1 (en) * 1990-07-24 1992-01-29 Merrell Dow Pharmaceuticals Inc. Novel carbocyclic analogs of certain nucleosides
EP0477871A3 (en) * 1990-09-28 1992-12-02 Nippon Kayaku Kabushiki Kaisha Antiviral composition, containing guanine derivatives

Also Published As

Publication number Publication date
HU9501627D0 (en) 1995-08-28
ATE153533T1 (de) 1997-06-15
HUT72604A (en) 1996-05-28
GR3024289T3 (en) 1997-10-31
IL107818A (en) 2000-01-31
DE69311135D1 (de) 1997-07-03
WO1994012188A1 (en) 1994-06-09
KR950703976A (ko) 1995-11-17
AU5549594A (en) 1994-06-22
EP0671918A1 (en) 1995-09-20
EP0671918B1 (en) 1997-05-28
IL107818A0 (en) 1994-04-12
NO952212L (no) 1995-06-02
CA2150671C (en) 2000-12-26
JPH08503942A (ja) 1996-04-30
AU678789B2 (en) 1997-06-12
KR100297568B1 (ko) 2001-11-14
DK0671918T3 (da) 1997-06-16
ES2105599T3 (es) 1997-10-16
NO952212D0 (no) 1995-06-02
CA2150671A1 (en) 1994-06-09
MX9307639A (es) 1994-06-30
NZ258015A (en) 1997-01-29
DE69311135T2 (de) 1997-09-25

Similar Documents

Publication Publication Date Title
HK1018595A1 (en) Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis
MY104575A (en) Therapeutic nucleosides.
MY104043A (en) Therapeutic nucleosides.
CA2130275A1 (en) Use of Substituted Adenine Derivatives for Treating Multiple Sclerosis
NZ500763A (en) Use of PEG 12000-IFN alpha in treating viral infection
ATE190064T1 (de) Kombination therapeutische nukleoside mit weiteren therapeutisch wirksamen komponenten.
MY130035A (en) Antiviral compounds
MY105855A (en) Therapeutic nucleotides.
ZA938915B (en) Treatment of viral infections by conjunctive therapy with acyclovir-like compounds and a 2'-vynyl substituted nucleoside analog
CA2142862A1 (en) Method for Inhibiting HIV Replication Using IL-4
AU2211592A (en) Method of treatment for latent virus infection
ES8700940A1 (es) Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus
EP1143981A4 (en) TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS
GEP19991514B (en) Method for Treatment with Interferon
MX9708885A (es) Uso de ribavirin e interferon alfa para el tratamiento de hepatitis c.
MY119359A (en) Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis.
MY102905A (en) Therapeutic nucleosides
UA13401C2 (uk) Ветеринарний препарат для профілактики та лікування хвороб вірусної та бактеріальної природи